“…used as potential P. aeruginosa vaccines. These include LPS [4], endotoxin protein [5], exotoxin [6] 'slime' polysaccharides [7] 'slime' glycolipoprotein [8], cell wall extracts [9], membrane proteins [10], proteoids (protease-elastase) [11], flagella [12], pill [13] and ribosomal [3] as well as other preparations [1][2][3]. Most of these preparations were found to significantly reduce the incidence of animal mortality due to Pseudomonas infection, some of them without and others with visible deleterious side-effects [1][2][3] as well as varying degrees of success in coping with the variability of the serotypes involved in the Pseudomonas infections [1-31.…”